Aspirin Eugenol Ester Reduces H2O2-Induced Oxidative Stress of HUVECs via Mitochondria-Lysosome Axis
Identifieur interne : 000761 ( Pmc/Corpus ); précédent : 000760; suivant : 000762Aspirin Eugenol Ester Reduces H2O2-Induced Oxidative Stress of HUVECs via Mitochondria-Lysosome Axis
Auteurs : Mei-Zhou Huang ; Ya-Jun Yang ; Xi-Wang Liu ; Zhe Qin ; Jian-Yong LiSource :
- Oxidative Medicine and Cellular Longevity [ 1942-0900 ] ; 2019.
Abstract
The oxidative stress of vessel endothelium is a major risk factor of cardiovascular disorders. Antioxidative stress drugs are widely used in cardiovascular therapy. Aspirin eugenol ester (AEE) is a new pharmaceutical compound synthesized by esterification reaction of aspirin with eugenols and possesses antioxidative activity. The present study was designed to investigate the mechanism how AEE protects human umbilical vein endothelial cells (HUVECs) from H2O2-induced oxidative stress. H2O2 was given to the HUVECs with or without AEE pretreatment. Changes in the oxidative stress-related factors, including those related to the mitochondria-lysosome axis, were determined with Western blotting, cellular immunofluorescence, and enzyme activity test. The results showed that, in the HUVECs, 300
Url:
DOI: 10.1155/2019/8098135
PubMed: 31583045
PubMed Central: 6754946
Links to Exploration step
PMC:6754946Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Aspirin Eugenol Ester Reduces H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Stress of HUVECs via Mitochondria-Lysosome Axis</title><author><name sortKey="Huang, Mei Zhou" sort="Huang, Mei Zhou" uniqKey="Huang M" first="Mei-Zhou" last="Huang">Mei-Zhou Huang</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author><author><name sortKey="Yang, Ya Jun" sort="Yang, Ya Jun" uniqKey="Yang Y" first="Ya-Jun" last="Yang">Ya-Jun Yang</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author><author><name sortKey="Liu, Xi Wang" sort="Liu, Xi Wang" uniqKey="Liu X" first="Xi-Wang" last="Liu">Xi-Wang Liu</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author><author><name sortKey="Qin, Zhe" sort="Qin, Zhe" uniqKey="Qin Z" first="Zhe" last="Qin">Zhe Qin</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author><author><name sortKey="Li, Jian Yong" sort="Li, Jian Yong" uniqKey="Li J" first="Jian-Yong" last="Li">Jian-Yong Li</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">31583045</idno><idno type="pmc">6754946</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754946</idno><idno type="RBID">PMC:6754946</idno><idno type="doi">10.1155/2019/8098135</idno><date when="2019">2019</date><idno type="wicri:Area/Pmc/Corpus">000761</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000761</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Aspirin Eugenol Ester Reduces H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Stress of HUVECs via Mitochondria-Lysosome Axis</title><author><name sortKey="Huang, Mei Zhou" sort="Huang, Mei Zhou" uniqKey="Huang M" first="Mei-Zhou" last="Huang">Mei-Zhou Huang</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author><author><name sortKey="Yang, Ya Jun" sort="Yang, Ya Jun" uniqKey="Yang Y" first="Ya-Jun" last="Yang">Ya-Jun Yang</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author><author><name sortKey="Liu, Xi Wang" sort="Liu, Xi Wang" uniqKey="Liu X" first="Xi-Wang" last="Liu">Xi-Wang Liu</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author><author><name sortKey="Qin, Zhe" sort="Qin, Zhe" uniqKey="Qin Z" first="Zhe" last="Qin">Zhe Qin</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author><author><name sortKey="Li, Jian Yong" sort="Li, Jian Yong" uniqKey="Li J" first="Jian-Yong" last="Li">Jian-Yong Li</name><affiliation><nlm:aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</nlm:aff></affiliation></author></analytic><series><title level="j">Oxidative Medicine and Cellular Longevity</title><idno type="ISSN">1942-0900</idno><idno type="eISSN">1942-0994</idno><imprint><date when="2019">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The oxidative stress of vessel endothelium is a major risk factor of cardiovascular disorders. Antioxidative stress drugs are widely used in cardiovascular therapy. Aspirin eugenol ester (AEE) is a new pharmaceutical compound synthesized by esterification reaction of aspirin with eugenols and possesses antioxidative activity. The present study was designed to investigate the mechanism how AEE protects human umbilical vein endothelial cells (HUVECs) from H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. H<sub>2</sub>O<sub>2</sub> was given to the HUVECs with or without AEE pretreatment. Changes in the oxidative stress-related factors, including those related to the mitochondria-lysosome axis, were determined with Western blotting, cellular immunofluorescence, and enzyme activity test. The results showed that, in the HUVECs, 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> treatment significantly increased the apoptosis rate, MDA concentration, reactive oxygen species (ROS) production, mitochondrial membrane potential, expression of Bax and mature cathepsin D (CTSD), and activity of CTSD and Caspase3 (Cas3) but decreased the expression of Bcl2 and lysosomal membrane stability, while in the HUVECs pretreated with AEE, the above changes caused by either the stimulatory or the inhibitory effect of H<sub>2</sub>O<sub>2</sub> on the relevant factors were significantly reduced. AEE pretreatment significantly enhanced the activity of cellular superoxide dismutase and glutathione peroxidase in the HUVECs. Our findings suggest that AEE effectively reduced H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in the HUVECs via mitochondria-lysosome axis.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Tikkanen, E" uniqKey="Tikkanen E">E. Tikkanen</name></author><author><name sortKey="Gustafsson, S" uniqKey="Gustafsson S">S. Gustafsson</name></author><author><name sortKey="Ingelsson, E" uniqKey="Ingelsson E">E. Ingelsson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Roever, L" uniqKey="Roever L">L. Roever</name></author><author><name sortKey="Tse, G" uniqKey="Tse G">G. Tse</name></author><author><name sortKey="Biondi Zoccai, G" uniqKey="Biondi Zoccai G">G. Biondi-Zoccai</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cai, H" uniqKey="Cai H">H. Cai</name></author><author><name sortKey="Harrison, D G" uniqKey="Harrison D">D. G. Harrison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Davel, A P" uniqKey="Davel A">A. P. Davel</name></author><author><name sortKey="Wenceslau, C F" uniqKey="Wenceslau C">C. F. Wenceslau</name></author><author><name sortKey="Akamine, E H" uniqKey="Akamine E">E. H. Akamine</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Incalza, M A" uniqKey="Incalza M">M. A. Incalza</name></author><author><name sortKey="D Oria, R" uniqKey="D Oria R">R. D'Oria</name></author><author><name sortKey="Natalicchio, A" uniqKey="Natalicchio A">A. Natalicchio</name></author><author><name sortKey="Perrini, S" uniqKey="Perrini S">S. Perrini</name></author><author><name sortKey="Laviola, L" uniqKey="Laviola L">L. Laviola</name></author><author><name sortKey="Giorgino, F" uniqKey="Giorgino F">F. Giorgino</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ciccone, M" uniqKey="Ciccone M">M. Ciccone</name></author><author><name sortKey="Pestrichella, V" uniqKey="Pestrichella V">V. Pestrichella</name></author><author><name sortKey="Rossi, O" uniqKey="Rossi O">O. Rossi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Matsuoka, H" uniqKey="Matsuoka H">H. Matsuoka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Loscalzo, J" uniqKey="Loscalzo J">J. Loscalzo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Morawietz, H" uniqKey="Morawietz H">H. Morawietz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Muller, G" uniqKey="Muller G">G. Muller</name></author><author><name sortKey="Goettsch, C" uniqKey="Goettsch C">C. Goettsch</name></author><author><name sortKey="Morawietz, H" uniqKey="Morawietz H">H. Morawietz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mo, J" uniqKey="Mo J">J. Mo</name></author><author><name sortKey="Yang, R" uniqKey="Yang R">R. Yang</name></author><author><name sortKey="Li, F" uniqKey="Li F">F. Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, H Y" uniqKey="Lee H">H. Y. Lee</name></author><author><name sortKey="Kim, S W" uniqKey="Kim S">S. W. Kim</name></author><author><name sortKey="Lee, G H" uniqKey="Lee G">G. H. Lee</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, C" uniqKey="Chen C">C. Chen</name></author><author><name sortKey="Lin, T" uniqKey="Lin T">T. Lin</name></author><author><name sortKey="Shieh, Y" uniqKey="Shieh Y">Y. Shieh</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ito, M" uniqKey="Ito M">M. Ito</name></author><author><name sortKey="Murakami, K" uniqKey="Murakami K">K. Murakami</name></author><author><name sortKey="Yoshino, M" uniqKey="Yoshino M">M. Yoshino</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nagababu, E" uniqKey="Nagababu E">E. Nagababu</name></author><author><name sortKey="Rifkind, J M" uniqKey="Rifkind J">J. M. Rifkind</name></author><author><name sortKey="Boindala, S" uniqKey="Boindala S">S. Boindala</name></author><author><name sortKey="Nakka, L" uniqKey="Nakka L">L. Nakka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Magalhaes, C B" uniqKey="Magalhaes C">C. B. Magalhães</name></author><author><name sortKey="Riva, D R" uniqKey="Riva D">D. R. Riva</name></author><author><name sortKey="Depaula, L J" uniqKey="Depaula L">L. J. DePaula</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bezerra, D P" uniqKey="Bezerra D">D. P. Bezerra</name></author><author><name sortKey="Militao, G C G" uniqKey="Militao G">G. C. G. Militao</name></author><author><name sortKey="De Morais, M C" uniqKey="De Morais M">M. C. de Morais</name></author><author><name sortKey="De Sousa, D P" uniqKey="De Sousa D">D. P. de Sousa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Park, B S" uniqKey="Park B">B. S. Park</name></author><author><name sortKey="Song, Y S" uniqKey="Song Y">Y. S. Song</name></author><author><name sortKey="Yee, S B" uniqKey="Yee S">S. B. Yee</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gerosa, R" uniqKey="Gerosa R">R. Gerosa</name></author><author><name sortKey="Borin, M" uniqKey="Borin M">M. Borin</name></author><author><name sortKey="Menegazzi, G" uniqKey="Menegazzi G">G. Menegazzi</name></author><author><name sortKey="Puttini, M" uniqKey="Puttini M">M. Puttini</name></author><author><name sortKey="Cavalleri, G" uniqKey="Cavalleri G">G. Cavalleri</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Soundran, V" uniqKey="Soundran V">V. Soundran</name></author><author><name sortKey="Namagiri, T" uniqKey="Namagiri T">T. Namagiri</name></author><author><name sortKey="Manonayaki, S" uniqKey="Manonayaki S">S. Manonayaki</name></author><author><name sortKey="Vanithakumari, G" uniqKey="Vanithakumari G">G. Vanithakumari</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nascimento Silva, V" uniqKey="Nascimento Silva V">V. Nascimento-Silva</name></author><author><name sortKey="Arruda, M A" uniqKey="Arruda M">M. A. Arruda</name></author><author><name sortKey="Barja Fidalgo, C" uniqKey="Barja Fidalgo C">C. Barja-Fidalgo</name></author><author><name sortKey="Fierro, I M" uniqKey="Fierro I">I. M. Fierro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kuhn, W" uniqKey="Kuhn W">W. Kuhn</name></author><author><name sortKey="Muller, T" uniqKey="Muller T">T. Muller</name></author><author><name sortKey="Buttner, T" uniqKey="Buttner T">T. Buttner</name></author><author><name sortKey="Gerlach, M" uniqKey="Gerlach M">M. Gerlach</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Demirci, B" uniqKey="Demirci B">B. Demirci</name></author><author><name sortKey="Demir, O" uniqKey="Demir O">O. Demir</name></author><author><name sortKey="Dost, T" uniqKey="Dost T">T. Dost</name></author><author><name sortKey="Birincioglu, M" uniqKey="Birincioglu M">M. Birincioglu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, J Y" uniqKey="Li J">J. Y. Li</name></author><author><name sortKey="Yu, Y G" uniqKey="Yu Y">Y. G. Yu</name></author><author><name sortKey="Wang, Q W" uniqKey="Wang Q">Q. W. Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, J Y" uniqKey="Li J">J. Y. Li</name></author><author><name sortKey="Yu, Y G" uniqKey="Yu Y">Y. G. Yu</name></author><author><name sortKey="Yang, Y J" uniqKey="Yang Y">Y. J. Yang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Huang, M Z" uniqKey="Huang M">M. Z. Huang</name></author><author><name sortKey="Yang, Y J" uniqKey="Yang Y">Y. J. Yang</name></author><author><name sortKey="Liu, X W" uniqKey="Liu X">X. W. Liu</name></author><author><name sortKey="Qin, Z" uniqKey="Qin Z">Z. Qin</name></author><author><name sortKey="Li, J Y" uniqKey="Li J">J. Y. Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rizzuto, R" uniqKey="Rizzuto R">R. Rizzuto</name></author><author><name sortKey="Pinton, P" uniqKey="Pinton P">P. Pinton</name></author><author><name sortKey="De Stefani, D" uniqKey="De Stefani D">D. De Stefani</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Boya, P" uniqKey="Boya P">P. Boya</name></author><author><name sortKey="Gonzalez Polo, R A" uniqKey="Gonzalez Polo R">R. A. Gonzalez-Polo</name></author><author><name sortKey="Poncet, D" uniqKey="Poncet D">D. Poncet</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Appelqvist, H" uniqKey="Appelqvist H">H. Appelqvist</name></author><author><name sortKey="Johansson, A C" uniqKey="Johansson A">A. C. Johansson</name></author><author><name sortKey="Linderoth, E" uniqKey="Linderoth E">E. Linderoth</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Brunk, U T" uniqKey="Brunk U">U. T. Brunk</name></author><author><name sortKey="Neuzil, J" uniqKey="Neuzil J">J. Neuzil</name></author><author><name sortKey="Eaton, J W" uniqKey="Eaton J">J. W. Eaton</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Temkin, V" uniqKey="Temkin V">V. Temkin</name></author><author><name sortKey="Liu, H T" uniqKey="Liu H">H. T. Liu</name></author><author><name sortKey="Ma, Y Y" uniqKey="Ma Y">Y. Y. Ma</name></author><author><name sortKey="Pope, R M" uniqKey="Pope R">R. M. Pope</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Thorin, E" uniqKey="Thorin E">E. Thorin</name></author><author><name sortKey="Shreeve, S M" uniqKey="Shreeve S">S. M. Shreeve</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dzugkoeva, F S" uniqKey="Dzugkoeva F">F. S. Dzugkoeva</name></author><author><name sortKey="Mozhaeva, I V" uniqKey="Mozhaeva I">I. V. Mozhaeva</name></author><author><name sortKey="Dzugkoev, S G" uniqKey="Dzugkoev S">S. G. Dzugkoev</name></author><author><name sortKey="Margieva, O I" uniqKey="Margieva O">O. I. Margieva</name></author><author><name sortKey="Tedtoeva, A I" uniqKey="Tedtoeva A">A. I. Tedtoeva</name></author><author><name sortKey="Otiev, M A" uniqKey="Otiev M">M. A. Otiev</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Czerska, M" uniqKey="Czerska M">M. Czerska</name></author><author><name sortKey="Mikolajewska, K" uniqKey="Mikolajewska K">K. Mikolajewska</name></author><author><name sortKey="Zielinski, M" uniqKey="Zielinski M">M. Zielinski</name></author><author><name sortKey="Gromadzinska, J" uniqKey="Gromadzinska J">J. Gromadzinska</name></author><author><name sortKey="Wasowicz, W" uniqKey="Wasowicz W">W. Wasowicz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Halliwell, B" uniqKey="Halliwell B">B. Halliwell</name></author><author><name sortKey="Whiteman, M" uniqKey="Whiteman M">M. Whiteman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, Y K" uniqKey="Wang Y">Y. K. Wang</name></author><author><name sortKey="Hong, Y J" uniqKey="Hong Y">Y. J. Hong</name></author><author><name sortKey="Wei, M" uniqKey="Wei M">M. Wei</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jones, D P" uniqKey="Jones D">D. P. Jones</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Buttke, T M" uniqKey="Buttke T">T. M. Buttke</name></author><author><name sortKey="Sandstrom, P A" uniqKey="Sandstrom P">P. A. Sandstrom</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mates, J M" uniqKey="Mates J">J. M. Mates</name></author><author><name sortKey="Segura, J A" uniqKey="Segura J">J. A. Segura</name></author><author><name sortKey="Alonso, F J" uniqKey="Alonso F">F. J. Alonso</name></author><author><name sortKey="Marquez, J" uniqKey="Marquez J">J. Marquez</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kurz, T" uniqKey="Kurz T">T. Kurz</name></author><author><name sortKey="Terman, A" uniqKey="Terman A">A. Terman</name></author><author><name sortKey="Gustafsson, B" uniqKey="Gustafsson B">B. Gustafsson</name></author><author><name sortKey="Brunk, U T" uniqKey="Brunk U">U. T. Brunk</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sinha, K" uniqKey="Sinha K">K. Sinha</name></author><author><name sortKey="Das, J" uniqKey="Das J">J. Das</name></author><author><name sortKey="Pal, P B" uniqKey="Pal P">P. B. Pal</name></author><author><name sortKey="Sil, P C" uniqKey="Sil P">P. C. Sil</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cocchiaro, P" uniqKey="Cocchiaro P">P. Cocchiaro</name></author><author><name sortKey="Fox, C" uniqKey="Fox C">C. Fox</name></author><author><name sortKey="Tregidgo, N W" uniqKey="Tregidgo N">N. W. Tregidgo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Blomgran, R" uniqKey="Blomgran R">R. Blomgran</name></author><author><name sortKey="Stendahl, O" uniqKey="Stendahl O">O. Stendahl</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Johansson, A C" uniqKey="Johansson A">A. C. Johansson</name></author><author><name sortKey="Appelqvist, H" uniqKey="Appelqvist H">H. Appelqvist</name></author><author><name sortKey="Nilsson, C" uniqKey="Nilsson C">C. Nilsson</name></author><author><name sortKey="K Gedal, K" uniqKey="K Gedal K">K. Kågedal</name></author><author><name sortKey="Roberg, K" uniqKey="Roberg K">K. Roberg</name></author><author><name sortKey="Ollinger, K" uniqKey="Ollinger K">K. Öllinger</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Terman, A" uniqKey="Terman A">A. Terman</name></author><author><name sortKey="Gustafsson, B" uniqKey="Gustafsson B">B. Gustafsson</name></author><author><name sortKey="Brunk, U T" uniqKey="Brunk U">U. T. Brunk</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="publisher-id">OMCL</journal-id><journal-title-group><journal-title>Oxidative Medicine and Cellular Longevity</journal-title></journal-title-group><issn pub-type="ppub">1942-0900</issn><issn pub-type="epub">1942-0994</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31583045</article-id><article-id pub-id-type="pmc">6754946</article-id><article-id pub-id-type="doi">10.1155/2019/8098135</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Aspirin Eugenol Ester Reduces H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Stress of HUVECs via Mitochondria-Lysosome Axis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2538-0217</contrib-id><name><surname>Huang</surname><given-names>Mei-Zhou</given-names></name><xref ref-type="aff" rid="I1"></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9651-8549</contrib-id><name><surname>Yang</surname><given-names>Ya-Jun</given-names></name><xref ref-type="aff" rid="I1"></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1623-0308</contrib-id><name><surname>Liu</surname><given-names>Xi-Wang</given-names></name><xref ref-type="aff" rid="I1"></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5417-5285</contrib-id><name><surname>Qin</surname><given-names>Zhe</given-names></name><xref ref-type="aff" rid="I1"></xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3317-0666</contrib-id><name><surname>Li</surname><given-names>Jian-Yong</given-names></name><email>lijy1971@163.com</email><xref ref-type="aff" rid="I1"></xref></contrib></contrib-group><aff id="I1">Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China</aff><author-notes><fn fn-type="other"><p>Academic Editor: Maria R. Ciriolo</p></fn></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>9</day><month>9</month><year>2019</year></pub-date><volume>2019</volume><elocation-id>8098135</elocation-id><history><date date-type="received"><day>14</day><month>10</month><year>2018</year></date><date date-type="rev-recd"><day>12</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>7</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>Copyright © 2019 Mei-Zhou Huang et al.</copyright-statement><copyright-year>2019</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The oxidative stress of vessel endothelium is a major risk factor of cardiovascular disorders. Antioxidative stress drugs are widely used in cardiovascular therapy. Aspirin eugenol ester (AEE) is a new pharmaceutical compound synthesized by esterification reaction of aspirin with eugenols and possesses antioxidative activity. The present study was designed to investigate the mechanism how AEE protects human umbilical vein endothelial cells (HUVECs) from H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. H<sub>2</sub>O<sub>2</sub> was given to the HUVECs with or without AEE pretreatment. Changes in the oxidative stress-related factors, including those related to the mitochondria-lysosome axis, were determined with Western blotting, cellular immunofluorescence, and enzyme activity test. The results showed that, in the HUVECs, 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> treatment significantly increased the apoptosis rate, MDA concentration, reactive oxygen species (ROS) production, mitochondrial membrane potential, expression of Bax and mature cathepsin D (CTSD), and activity of CTSD and Caspase3 (Cas3) but decreased the expression of Bcl2 and lysosomal membrane stability, while in the HUVECs pretreated with AEE, the above changes caused by either the stimulatory or the inhibitory effect of H<sub>2</sub>O<sub>2</sub> on the relevant factors were significantly reduced. AEE pretreatment significantly enhanced the activity of cellular superoxide dismutase and glutathione peroxidase in the HUVECs. Our findings suggest that AEE effectively reduced H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in the HUVECs via mitochondria-lysosome axis.</p></abstract><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>31872518</award-id><award-id>31572573</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>The most global deaths and disability-adjusted life year events are associated with the cardiovascular diseases [<xref rid="B1" ref-type="bibr">1</xref>–<xref rid="B3" ref-type="bibr">3</xref>]. Endothelial dysfunction is a key weathercock of cardiovascular diseases [<xref rid="B4" ref-type="bibr">4</xref>–<xref rid="B6" ref-type="bibr">6</xref>]. Investigation of the incentives and mechanism of endothelial dysfunction and development of new drugs against endothelial dysfunction benefits the prevention and treatment of cardiovascular diseases. In recent years, it has been believed that oxidative stress is a key risk factor of endothelial dysfunction [<xref rid="B7" ref-type="bibr">7</xref>–<xref rid="B11" ref-type="bibr">11</xref>]. The drugs and active compounds with antioxidative activity tend to be the potential agents for the prevention of cardiovascular diseases [<xref rid="B12" ref-type="bibr">12</xref>–<xref rid="B14" ref-type="bibr">14</xref>]. Low concentrations of eugenol are known to act as an antioxidant and anti-inflammatory agent [<xref rid="B15" ref-type="bibr">15</xref>–<xref rid="B18" ref-type="bibr">18</xref>], but the instability and cytotoxicity of eugenol limit its application in antioxidative treatment [<xref rid="B19" ref-type="bibr">19</xref>–<xref rid="B21" ref-type="bibr">21</xref>]. It has been reported that low dose of aspirin protects the cell from oxidative stress [<xref rid="B22" ref-type="bibr">22</xref>–<xref rid="B24" ref-type="bibr">24</xref>]. Aspirin eugenol ester (AEE) is a new pharmaceutical compound synthesized by esterification reaction between aspirin and eugenols [<xref rid="B25" ref-type="bibr">25</xref>]. Previous studies have shown that AEE possesses desired antioxidant pharmacological activity and effectively reduced the side effect of both eugenol and aspirin [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>]. Moreover, AEE could reduce the H<sub>2</sub>O<sub>2</sub>-induced dysfunctions of NO in the vascular endothelial cells by enhancing the antioxidant capacity of cells [<xref rid="B27" ref-type="bibr">27</xref>]. Oxidative stress is an important factor causing dysfunctions of NO. To clarify the biological mechanism responsible for antioxidative effect will be helpful to further understand the effect of AEE on the H<sub>2</sub>O<sub>2</sub>-induced dysfunctions of NO. It has been shown that mitochondria play essential roles in oxidative balance of the cell [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>]. Lysosome regulates the cellular redox status by altering the autophagy degradation pathway, inhibiting lysosome enzyme function and reducing lysosome membrane damage [<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>]. Mitochondria and lysosome regulate the cellular redox status interdependently [<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B32" ref-type="bibr">32</xref>]. In the present study, the mechanism how AEE protects cell from oxidative stress was examined via mitochondria-lysosome axis. This will help in understanding the effect of AEE on cardiovascular diseases.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Chemicals</title><p>AEE transparent crystal with the purity of 99.5% by RE-HPLC was prepared in Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS. H<sub>2</sub>O<sub>2</sub> solution (cat number: 323381), dimethyl sulfoxide (DMSO), reactive oxygen species assay kit, and trypsin-EDTA were supplied by Sigma (St. Louis, MO). Cell Counting Kit-8 (CCK-8) was from MedChemExpress (NJ, USA), DMEM/F12 (1 : 1), and fetal bovine serum was from Gibco (NY, USA). LysoTracker Red probe, Hoechst 33342 staining solution, cellular glutathione peroxidase assay kit, Cu/Zn-SOD and Mn-SOD assay kit, and mitochondrial membrane potential assay kit were purchased from Beyotime (Shanghai, China). MitoTracker Red CMXRos probe was from Thermo Scientific (MA, USA). Anti-Bid cleavage site, Anti-Bax, Anti-Bcl2, Anti-Bcl-XL, anti-Caspase3 (Cas3), anti-cytochrome C, and anti-Cathepsin D (CTSD) were purchased from Abcam (MA, USA) and the CTSD activity assay kit was from BioVision (CA, USA). An Annexin V/FITC apoptosis detection kit was from BD Biosciences (NY, USA). A Caspase-3 activity assay kit was from Cell Signaling Technology (MA, USA).</p></sec><sec id="sec2.2"><title>2.2. Cell Cultures and Cell Treatment</title><p>Human umbilical vein endothelial cells (ATCC® CRL-4053™) were purchased from ATCC (Rockville, MD). The cells were cultured in the cell culture flasks in DMEM/F12 (1 : 1) with 10% fetal bovine serum. Media were replaced every two days. Subcultures were performed with the trypsin-EDTA method. Experiments were subsequently conducted on 6-7 passages of cells.</p><p>HUVECs were randomly divided into 3 groups (<italic>n</italic> = 6): normal group, model group, and AEE pretreatment group. Cells in the normal group were incubated with the normal growth conditions. Those in the model group were incubated with the medium containing 300 <italic>μ</italic>M of H<sub>2</sub>O<sub>2</sub> for 6 h. In the AEE pretreatment groups, the cells were cultured with the medium containing different concentrations of AEE (0.5, 1, 2.0, and 4.0 <italic>μ</italic>M) for 24 h before they were incubated with medium containing 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h.</p></sec><sec id="sec2.3"><title>2.3. Apoptosis Detection with Flow Cytometry</title><p>In the HUVECs, the apoptosis induced by H<sub>2</sub>O<sub>2</sub> was detected quantitatively with Annexin V/FITC apoptosis detection kit and flow cytometry. Briefly, the cells were collected and washed three times with cold PBS. Then, they were incubated and stained with FITC-Annexin V and PI at room temperature for 15 min in the dark. The double stained cells were analyzed using flow cytometry, and the following controls were used to set up compensation and quadrants: unstained cells, cells stained with FITC-Annexin V, and cells stained with PI.</p></sec><sec id="sec2.4"><title>2.4. Intracellular and Mitochondrial ROS Measurement</title><p>Intracellular ROS was measured with reactive oxygen species assay kits following the manufacturer's instructions. Briefly, the HUVECs were cultured on the 24-well glass bottom cell culture plate and treated with AEE and H<sub>2</sub>O<sub>2</sub>. Then, the cells were incubated with the ROS detection work solutions (10 <italic>μ</italic>M) at 37°C for 20 min in the dark. The relative fluorescence intensity of the cells was measured using a laser scanning confocal microscope (ZEISS LSM-800, Jena, Germany).</p><p>The mitochondrial ROS was detected by a MitoSOX probe following the manufacturer's instructions. Briefly, the HUVECs were cultured on the 24-well glass bottom cell culture plate and treated with AEE and H<sub>2</sub>O<sub>2</sub>. Then, the cells were incubated with the MitoSOX probe work solutions (4 <italic>μ</italic>M) at 37°C for 10 min in the dark. The relative fluorescence intensity of the cells was measured using a laser scanning confocal microscope (ZEISS LSM-800, Jena, Germany).</p></sec><sec id="sec2.5"><title>2.5. Malondialdehyde (MDA), GSH/GSSG Ratio, and Activity of Sodium Oxide Dismutase (SOD) and Glutathione Peroxidase (GSH-Px) Assay</title><p>The concentrations of MDA, GSH/GSSG ratio, SOD, and glutathione peroxidase activity in the HUVECs were determined using the commercial kits according to the manufacturer's protocols (see <xref ref-type="sec" rid="sec2.1">Section 2.1</xref> for details).</p></sec><sec id="sec2.6"><title>2.6. Measurement of Mitochondrial Membrane Potential</title><p>A mitochondrial membrane potential assay kit was used to determine the mitochondrial membrane potential. Briefly, the HUVECs were cultured on the 24-well glass bottom cell culture plate and treated with AEE and H<sub>2</sub>O<sub>2</sub>. Then, the cells were incubated with JC-1 work solutions (5 <italic>μ</italic>M) at 37°C for 20 min in the dark. The relative fluorescence intensity of the cells was measured using a laser scanning confocal microscope (ZEISS LSM-800, Jena, Germany) with the positive control, in which the HUVECs were treated with CCCP (10 <italic>μ</italic>M) at 37°C for 20 min, then incubated with JC-1 work solutions (5 <italic>μ</italic>M) at 37°C for 20 min in the dark.</p></sec><sec id="sec2.7"><title>2.7. Lysosomal Membrane Stability Assay</title><p>Lysosomal membrane stability was determined with a LysoTracker Red probe. Briefly, the HUVECs were cultured on the 24-well glass bottom cell culture plate and treated with AEE and H<sub>2</sub>O<sub>2</sub>. Then, the cells were incubated with LysoTracker Red work solutions (10 nM) at 37°C for 40 min in the dark. The relative fluorescence intensity of the cells was measured using a laser scanning confocal microscope (ZEISS LSM-800, Jena, Germany). With the positive control, the HUVECs were treated with chloroquine (50 <italic>μ</italic>M), a lysosomal stabilizer, at 37°C for 24 h, then incubated with LysoTracker Red work solutions (10 nM) at 37°C for 40 min in the dark.</p></sec><sec id="sec2.8"><title>2.8. Cathepsin D (CTSD) Activity Assay</title><p>CTSD activity in the HUVECs was determined with an enzymatic assay method using a commercial kit according to the manufacturer's protocol (see <xref ref-type="sec" rid="sec2.1">Section 2.1</xref> for details).</p></sec><sec id="sec2.9"><title>2.9. Protein Expression Analysis</title><p>The expression of Bid, Bcl2, Bcl-XL, Cas3, and CTSD was evaluated by Western blot analysis. In brief, the total protein of the HUVECs was isolated with RIPA lysis buffer. The concentration was quantified using the BCA method. SDS-PAGE (10%) electrophoresis and transfer of the separated proteins onto polyvinylidene fluoride membrane (Merck Millipore) were performed using standard procedures. The blots were incubated with primary antibodies against Bid, Bcl2, Bcl-XL, Cas3, CTSD, and internal control <italic>β</italic>-actin, and then incubated with horseradish peroxidase-conjugated secondary antibody. The results were observed using the Bio-Rad ChemiDoc™ MP imaging system and normalized to the corresponding internal control of <italic>β</italic>-actin for eliminating the variation of the total protein.</p><p>The expression of cytochrome C and Bax was evaluated with immunofluorescence. Briefly, the cells were cultured on glass coverslips in the medium and the mitochondria were labeled with the CMXRos probe; then, immunofluorescence analyzes 4% paraformaldehyde–fixed. 0.1% Triton X-100 permeabilized the cells labeling the primary antibody against cytochrome C and Bax, and then, they were incubated with the Alexa Fluor®-conjugated secondary antibody. The relative fluorescence intensity of the cells was measured using a laser scanning confocal microscope (ZEISS LSM-800, Jena, Germany). The colocalization data of cytochrome c and mitochondria have been acquired by ZEN blue software (ZEISS, Jena, German) following with the colocalization analysis.</p></sec><sec id="sec2.10"><title>2.10. The Activity of Cas3 Assay</title><p>Cas3 activity in the HUVECs was determined with the enzymatic assay method using the Cas3 assay kit according to the manufacturer's protocol.</p></sec><sec id="sec2.11"><title>2.11. Transfection of HUVECs with Lentivirus</title><p>The lentivirus labeled ubiquitin IRES-puromycin containing short interference (si) RNA oligonucleotides against Bcl2 (siBcl2) or control siRNA was used to transfect HUVECs for knockdown experiments, and the HUVECs were transduced with a lentivirus expressing Bcl2 gene labeled ubiquitin IRES-puromycin for overexpression experiments. The positive cells were selected using puromycin.</p></sec><sec id="sec2.12"><title>2.12. Statistical Analysis</title><p>All experiments and data analyses were carried out according to the blinding principles. Statistical analysis was performed using the SAS 9.2 (SAS Institute Inc., NC, USA). Where applicable, the values from treatment groups were normalized to the corresponding control values. All data were presented as means ± SD. The differences between groups were analyzed via one-way ANOVA followed with Duncan's multiple comparisons. Statistical significance was considered at <italic>p</italic> < 0.05.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. AEE Attenuated H<sub>2</sub>O<sub>2</sub>-Induced Apoptosis in HUVECs</title><p>To verify the effects of AEE on apoptosis in HUVECs, cells were incubated with AEE at 0.5, 1.0, 2.0, and 4.0 <italic>μ</italic>M for 24 h in the absence of H<sub>2</sub>O<sub>2</sub>. As shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>, different concentrations of AEE did not cause the apoptosis in HUVECs. Treatment of HUVECs with 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h significantly increased the apoptosis rate of HUVECs. Reincubating with AEE (0.5, 1.0, 2.0, and 4.0 <italic>μ</italic>M) significantly attenuated H<sub>2</sub>O<sub>2</sub>-induced apoptosis in HUVECs (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="sec3.2"><title>3.2. AEE Decreased Lipid Peroxidation and Enhanced Antioxidant Ability in the HUVECs</title><p>The levels of MDA were not different in the HUVECs incubated with different concentrations of AEE (0, 0.5, 1.0, 2.0, and 4.0 <italic>μ</italic>M) for 24 h in the absence of H<sub>2</sub>O<sub>2</sub>. Treatment of HUVECs at 300 <italic>μ</italic>M of H<sub>2</sub>O<sub>2</sub> for 6 h significantly increased the levels of MDA. However, in the cells pretreated with AEE (0.5, 0.5, 1.0, 2.0, and 4.0 <italic>μ</italic>M), the stimulatory effect of H<sub>2</sub>O<sub>2</sub> on MDA was significantly reduced (<xref ref-type="fig" rid="fig2">Figure 2(a)</xref>).</p><p>After the HUVECs were incubated with different concentrations of AEE (0.5, 1.0, 2.0, and 4.0 <italic>μ</italic>M) for 24 h in the absence of H<sub>2</sub>O<sub>2</sub>, the GSH/GSSG ratio and the activity of SOD and GSH-Px were significantly increased. Preincubation with different concentrations of AEE significantly attenuated the decrease in the GSH/GSSG ratio and the activity of SOD and GSH-Px induced by 300 <italic>μ</italic>M of H<sub>2</sub>O<sub>2</sub> (Figures <xref ref-type="fig" rid="fig2">2(b)</xref>–<xref ref-type="fig" rid="fig2">2(d)</xref>).</p></sec><sec id="sec3.3"><title>3.3. AEE Ameliorated Lysosomal Disorder Induced by H<sub>2</sub>O<sub>2</sub></title><p>The expression and activity of CTSD were examined with Western blotting and enzyme activity test kit. In the control group, the expression of mature CTSD and the activity of CTSD were very low. After treatment with 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h, the mature CTSD and the activity of CTSD significantly increased. Pretreating HUVECs with 1 <italic>μ</italic>M AEE significantly ameliorated lysosomal disorder manifested as the increased CTSD activity and mature CTSD induced by H<sub>2</sub>O<sub>2</sub> (Figures <xref ref-type="fig" rid="fig3">3(a)</xref>–<xref ref-type="fig" rid="fig3">3(c)</xref>). The lysosomal membrane stability was measured with LysoTracker Red. The LysoTracker Red is an acidophilic dye, which can specifically target to the lysosome, and the LysoTracker fluorescence intensity depends on the acidity of the lysosome. After treatment of the cells with 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h, the LysoTracker fluorescence intensity significantly decreased compared with the normal group. Pretreating the HUVECs with 1 <italic>μ</italic>M AEE significantly mitigated the decrease in LysoTracker fluorescence intensity induced by H<sub>2</sub>O<sub>2</sub> (Figures <xref ref-type="fig" rid="fig3">3(d)</xref> and <xref ref-type="fig" rid="fig3">3(e)</xref>).</p></sec><sec id="sec3.4"><title>3.4. AEE Mitigated Mitochondrial Dysfunction Induced by H<sub>2</sub>O<sub>2</sub></title><p>A JC-1 probe was used to examine the mitochondrial membrane potential. As presented in Figures <xref ref-type="fig" rid="fig4">4(a)</xref> and <xref ref-type="fig" rid="fig4">4(b)</xref>, the JC-1 mainly showed the red fluorescence in the control group and mainly showed the green fluorescence in the positive control group and after treatment with 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h, the ratio of red to green fluorescence intensity significantly decreased compared with the control group, while in the HUVECs pretreated with 1 <italic>μ</italic>M AEE, the mitochondrial membrane potential was significantly higher than in the cells receiving H<sub>2</sub>O<sub>2</sub> induction alone (<italic>p</italic> < 0.05), indicating that the inhibitory effect of H<sub>2</sub>O<sub>2</sub> was significantly mitigated by the AEE treatment. The cellular and mitochondrial ROS were assayed with the corresponding fluorescence probe, respectively. The fluorescence intensity for ROS in HUVECs between different treatment groups was showed in Figures <xref ref-type="fig" rid="fig4">4(c)</xref> and <xref ref-type="fig" rid="fig4">4(d)</xref>. This illustrated that in the HUVECs preincubated with 1 <italic>μ</italic>M AEE, the increase in cellular and mitochondrial ROS induced by H<sub>2</sub>O<sub>2</sub> was significantly suppressed. The changes in mitochondrial cytochrome c were investigated via immunofluorescence. The mitochondria were labeled with the MitoTracker Red CMXRos probe (<xref ref-type="fig" rid="fig4">Figure 4(e)</xref>). In the control group, the cytochrome c is predominantly located in the mitochondria. However, after the HUVECs were treated with 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub>, the cytochrome c distributing outside the mitochondria increased significantly. In the HUVECs pretreated with 1 <italic>μ</italic>M AEE, the release of cytochrome c from mitochondria induced by H<sub>2</sub>O<sub>2</sub> was significantly reduced (<xref ref-type="fig" rid="fig4">Figure 4(f)</xref>). In short, 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> inductions caused mitochondrial dysfunction behaved as collapsed mitochondrial membrane potential, increased ROS production, and release of cytochrome c from mitochondria and those dysfunctions were significantly mitigated by AEE treatment.</p></sec><sec id="sec3.5"><title>3.5. AEE Prevented H<sub>2</sub>O<sub>2</sub>-Induced Mitochondrial and Lysosomal Dysfunction via Regulating the Bcl2 Family</title><sec id="sec3.5.1"><title>3.5.1. AEE Reduced the Changes in Proapoptotic and Antiapoptotic Proteins Induced by H<sub>2</sub>O<sub>2</sub></title><p>The expression of Bcl2, Bcl-xl, Bax, and Bid was examined with Western blotting and immunofluorescence. In the H<sub>2</sub>O<sub>2</sub>-treated HUVECs, the expression of proapoptotic proteins (Bax and activated Bid) was significantly upregulated while the antiapoptotic proteins (Bcl2 and Bcl-xl) were significantly downregulated. Those changes were reversed by pretreating HUVECs with 1 <italic>μ</italic>M AEE. The apoptotic executioner Cas3 was activated in the H<sub>2</sub>O<sub>2</sub>-treated HUVECs. After treatment with 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h, the mature Cas3 and its activity were significantly upregulated. Preincubating HUVECs with 1 <italic>μ</italic>M AEE reduced the changes in Cas3 induced by H<sub>2</sub>O<sub>2</sub> (Figures <xref ref-type="fig" rid="fig5">5(a)</xref>–<xref ref-type="fig" rid="fig5">5(d)</xref>).</p></sec><sec id="sec3.5.2"><title>3.5.2. Genetic Inhibition of Bcl2 Reduced the Effect of AEE on H<sub>2</sub>O<sub>2</sub>-Induced Mitochondrial and Lysosomal Dysfunction</title><p>The roles of Bcl2 in the protective effect of AEE on H<sub>2</sub>O<sub>2</sub>-induced mitochondrial and lysosomal dysfunction were investigated. The lentivirus labeled with ubiquitin IRES-puromycin containing siRNA oligonucleotides was used to silence Bcl2 expression. There were over 85% of positive HUVECs transfected with the lentivirus at 5 MOI (multiplicity of infection). The Bcl2 expression was significantly downregulated in the positive HUVECs compared with normal HUVECs. After the HUVECs with downregulated Bcl2 were given 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h, the mitochondrial membrane potential and lysosomal membrane stability significantly decreased while the ROS generation and the activity of Cas3 and CTSD significantly increased compared with those in the normal HUVECs induced by H<sub>2</sub>O<sub>2</sub>. Preincubating the Bcl2-inhibited HUVECs with AEE did not significantly reverse the changes induced by H<sub>2</sub>O<sub>2</sub> (Figures <xref ref-type="fig" rid="fig6">6(a)</xref>–<xref ref-type="fig" rid="fig6">6(f)</xref>).</p></sec><sec id="sec3.5.3"><title>3.5.3. Overexpression of Bcl2 Reduced the Mitochondrial and Lysosomal Dysfunction Induced by H<sub>2</sub>O<sub>2</sub></title><p>To confirm the role of Bcl2 in the mitochondrial lysosomal dysfunction induced by H<sub>2</sub>O<sub>2</sub>, HUVECs were transduced with lentivirus to overexpress Bcl2. Bcl2 overexpression significantly ameliorated mitochondrial and lysosomal disorders manifested as the increase in ROS generation and activity of Cas3 and CTSD induced by H<sub>2</sub>O<sub>2</sub> (Figures <xref ref-type="fig" rid="fig6">6(a)</xref>–<xref ref-type="fig" rid="fig6">6(f)</xref>).</p></sec></sec></sec><sec id="sec4"><title>4. Discussion</title><p>Vascular endothelial cells provide a haemocompatible vessel lining via regulating procoagulant and anticoagulant balance of endothelium [<xref rid="B33" ref-type="bibr">33</xref>]. The oxidative stress in vessel endothelium would disrupt the balance between anticoagulation and procoagulation to cause cardiovascular disorders [<xref rid="B33" ref-type="bibr">33</xref>]. In the present study, vessel endothelium played an important role in the processes of H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in the HUVECs. Our findings confirmed that the incubation of HUVECs with 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h caused oxidative stress, indicated by the unbalance between antioxidation and oxidation and the dysfunction of mitochondria and lysosome. To evaluate the oxidative stress of cells, many markers have been reported [<xref rid="B34" ref-type="bibr">34</xref>–<xref rid="B36" ref-type="bibr">36</xref>]. MDA is one of the end products of lipid peroxidation, which is recognized as a sentinel of the cellular oxidation status [<xref rid="B36" ref-type="bibr">36</xref>]. In the present study, the levels of MDA enhanced by H<sub>2</sub>O<sub>2</sub> induction were reduced in the AEE—preincubated HUVECs—and the optimal dose of AEE was found to be 1 <italic>μ</italic>M. The dysfunction of the antioxidant system is responsible for the generation of oxidative stress markers [<xref rid="B34" ref-type="bibr">34</xref>]. In the present study, the GSH/GSSG ratio and the activity of SOD and GSH-Px were altered by H<sub>2</sub>O<sub>2</sub>, which was consistent with the previous studies [<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>]. Pretreatment of the HUVECs with AEE increased the GSH/GSSG ratio and the activity of SOD and GSH-Px and also mitigated the disruption of the antioxidant system induced by H<sub>2</sub>O<sub>2</sub>, suggesting that AEE possessed a good antioxidant activity. This agreed with the previous <italic>in vivo</italic> study that AEE was potential antioxidant. It has been well known that oxidative stress is one of the causes of apoptosis [<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>]. In the present study, the incubation of the HUVECs with 300 <italic>μ</italic>M H<sub>2</sub>O<sub>2</sub> for 6 h caused apoptosis and it was significantly reduced by pretreating HUVECs with AEE. This suggests that apoptosis in the HUVECs be related with the unbalance of the oxidative status induced by H<sub>2</sub>O<sub>2</sub>.</p><p>Various events involved in oxidative stress and apoptosis are closely related with mitochondrial dysfunction, including generation of ROS, cellular unbalance of the redox status, changes in electron transport and mitochondrial transmembrane potential, release of apoptosis activators (such as cytochrome c), changes in the pro- and antiapoptotic Bcl-2 family proteins, and activation of downstream caspase family proteins [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. Consistent with these previous studies, our study showed that in the HUVECs with H<sub>2</sub>O<sub>2</sub>-induced oxidative stress there were various characteristics of the oxidative stress related with mitochondrial dysfunction, including increased ROS production, collapsed mitochondrial transmembrane potential, the release of cytochrome c from mitochondria, upregulated proapoptosis Bax and activated Bid, downregulated antiapoptosis Bcl2, and enhanced activity of Cas3. The H<sub>2</sub>O<sub>2</sub>-induced mitochondrial dysfunction was significantly reduced by AEE pretreatment in the HUVECs. In addition to the mitochondrial dysfunctions, the lysosomal dysfunction featured by the destruction of the lysosomal membrane and the increase in CTSD activity were observed in the HUVECs with H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. Again, AEE pretreatment in the HUVECs attenuated the CTSD activity and stabilized the lysosomal membrane. The roles of lysosomes in apoptosis and autophagy have been paid attention, and it has been reported that the lysosomal membrane was destructed by oxidative stress causing the release of CTSD from the lysosome, which activated caspases, Bid, and other potential targets responsible for apoptosis [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B43" ref-type="bibr">43</xref>–<xref rid="B45" ref-type="bibr">45</xref>]. In the present study, we speculated that the increased activation of Bid might be related with the increase in CTSD. Recently, studies on the mutual regulation of mitochondria and lysosome in the apoptosis have confirmed the “lysosomal-mitochondrial axis” theory [<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B46" ref-type="bibr">46</xref>].</p><p>To investigate the role of Bcl2 in the protective effect of AEE on H<sub>2</sub>O<sub>2</sub>-induced oxidative stress and lysosomal-mitochondrial axis of apoptosis in the HUVECs, the Bcl2 was knocked down or overexpressed by genetic intervention of Bcl2 proteins and this showed alteration in a variety of mitochondrial events, including mitochondrial transmembrane potential and release of proapoptotic and antiapoptotic factor from mitochondria. Bcl2 proteins inhibited caspase-dependent apoptosis; however, there were few reports showing influence of Bcl2 in lysosomal function in the apoptosis. In the present study, we demonstrated that Bcl2 overexpression significantly reduced H<sub>2</sub>O<sub>2</sub>-induced dysfunctions in mitochondria and lysosome systems, including increase in mitochondrial transmembrane potential and stabilizing lysosomal membrane and decrease in CTSD and Cas3 activity. The knockdown of Bcl2 did not cause the apoptosis in HUVECs but enhanced the mitochondrial and lysosomal dysfunctions induced by H<sub>2</sub>O<sub>2</sub>. It is interesting to note that those changes were not reversed by pretreating HUVECs with AEE. These findings suggested that Bcl2 play a vital role in the protective effect of AEE on H<sub>2</sub>O<sub>2</sub>-induced oxidative stress and apoptosis in the lysosomal-mitochondrial axis in HUVECs. Previous studies have confirmed that AEE has antithrombotic and antiatherosclerotic effects [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>]. The metabolomics studies suggested that the antiatherosclerotic effects of AEE might be related with its property of antioxidative stress [<xref rid="B26" ref-type="bibr">26</xref>]. In this study, the antioxidative stress effect of AEE was further confirmed <italic>in vitro</italic>. It is worth noticing that the findings of this study suggest that Bcl2 be an important regulation target of AEE to protect cells from oxidative stress. It has been believed that lysosome and mitochondria play important roles in the development of oxidative stress. Our study confirmed that the oxidative stress induced by H<sub>2</sub>O<sub>2</sub> was involved with the regulation of the lysosomal-mitochondrial axis. However, the interdependent relationships between lysosome and mitochondria are still unclear and further study is required to investigate the mechanisms.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>Our study demonstrated that AEE treatment significantly reduced H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in HUVECs via mitochondria-lysosome axis and Bcl2 was an important regulation target of AEE to protect cells from oxidative stress.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by the Special Fund for National Natural Science Foundation (Grant/Award numbers: 31572573 and 31872518). The authors would like to thank the personnel in the Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture, Key Laboratory of New Animal Drug Project of Gansu Province for their contribution to this project.</p></ack><sec sec-type="data-availability"><title>Data Availability</title><p>The data used to support the findings of this study are included within the article.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><collab>Global Burden of Cardiovascular Diseases Collaboration</collab><article-title>The burden of cardiovascular diseases among US States, 1990-2016</article-title><source><italic toggle="yes">JAMA Cardiology</italic></source><year>2018</year><volume>3</volume><issue>5</issue><fpage>375</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1001/jamacardio.2018.0385</pub-id><pub-id pub-id-type="other">2-s2.0-85049098293</pub-id><pub-id pub-id-type="pmid">29641820</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tikkanen</surname><given-names>E.</given-names></name><name><surname>Gustafsson</surname><given-names>S.</given-names></name><name><surname>Ingelsson</surname><given-names>E.</given-names></name></person-group><article-title>Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease: longitudinal analyses in the UK biobank study</article-title><source><italic toggle="yes">Circulation</italic></source><year>2018</year><volume>137</volume><issue>24</issue><fpage>2583</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.032432</pub-id><pub-id pub-id-type="other">2-s2.0-85045997887</pub-id><pub-id pub-id-type="pmid">29632216</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roever</surname><given-names>L.</given-names></name><name><surname>Tse</surname><given-names>G.</given-names></name><name><surname>Biondi-Zoccai</surname><given-names>G.</given-names></name></person-group><article-title>Trends in cardiovascular disease in Australia and in the world</article-title><source><italic toggle="yes">European Journal of Preventive Cardiology</italic></source><year>2018</year><volume>25</volume><issue>12</issue><fpage>1278</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1177/2047487318778339</pub-id><pub-id pub-id-type="other">2-s2.0-85047820789</pub-id><pub-id pub-id-type="pmid">29808763</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Harrison</surname><given-names>D. G.</given-names></name></person-group><article-title>Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress</article-title><source><italic toggle="yes">Circulation Research</italic></source><year>2000</year><volume>87</volume><issue>10</issue><fpage>840</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1161/01.RES.87.10.840</pub-id><pub-id pub-id-type="other">2-s2.0-0034634281</pub-id><pub-id pub-id-type="pmid">11073878</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davel</surname><given-names>A. P.</given-names></name><name><surname>Wenceslau</surname><given-names>C. F.</given-names></name><name><surname>Akamine</surname><given-names>E. H.</given-names></name><etal></etal></person-group><article-title>Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update</article-title><source><italic toggle="yes">Brazilian Journal of Medical and Biological Research</italic></source><year>2011</year><volume>44</volume><issue>9</issue><fpage>920</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X2011007500104</pub-id><pub-id pub-id-type="other">2-s2.0-80053331729</pub-id><pub-id pub-id-type="pmid">21956535</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Incalza</surname><given-names>M. A.</given-names></name><name><surname>D'Oria</surname><given-names>R.</given-names></name><name><surname>Natalicchio</surname><given-names>A.</given-names></name><name><surname>Perrini</surname><given-names>S.</given-names></name><name><surname>Laviola</surname><given-names>L.</given-names></name><name><surname>Giorgino</surname><given-names>F.</given-names></name></person-group><article-title>Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases</article-title><source><italic toggle="yes">Vascular Pharmacology</italic></source><year>2018</year><volume>100</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2017.05.005</pub-id><pub-id pub-id-type="other">2-s2.0-85020316170</pub-id><pub-id pub-id-type="pmid">28579545</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciccone</surname><given-names>M.</given-names></name><name><surname>Pestrichella</surname><given-names>V.</given-names></name><name><surname>Rossi</surname><given-names>O.</given-names></name><etal></etal></person-group><article-title>Oxidative stress is an early marker of endothelial dysfunction?</article-title><source><italic toggle="yes">Clinical Hemorheology and Microcirculation</italic></source><year>1999</year><volume>21</volume><issue>3-4</issue><fpage>341</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">10711767</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>H.</given-names></name></person-group><article-title>Endothelial dysfunction associated with oxidative stress in human</article-title><source><italic toggle="yes">Diabetes Research and Clinical Practice</italic></source><year>2001</year><volume>54</volume><issue>Supplement 2</issue><fpage>S65</fpage><lpage>S72</lpage><pub-id pub-id-type="doi">10.1016/S0168-8227(01)00337-0</pub-id><pub-id pub-id-type="other">2-s2.0-0035182326</pub-id><pub-id pub-id-type="pmid">11733111</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loscalzo</surname><given-names>J.</given-names></name></person-group><article-title>Oxidative stress in endothelial cell dysfunction and thrombosis</article-title><source><italic toggle="yes">Pathophysiology of Haemostasis and Thrombosis</italic></source><year>2002</year><volume>32</volume><issue>5-6</issue><fpage>359</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1159/000073600</pub-id><pub-id pub-id-type="other">2-s2.0-0142103861</pub-id><pub-id pub-id-type="pmid">13679676</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morawietz</surname><given-names>H.</given-names></name></person-group><article-title>Acromegaly and oxidative stress: impact on endothelial dysfunction and atherosclerosis</article-title><source><italic toggle="yes">Hormone and Metabolic Research</italic></source><year>2013</year><volume>45</volume><issue>4</issue><fpage>255</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1055/s-0033-1341495</pub-id><pub-id pub-id-type="other">2-s2.0-84876878888</pub-id><pub-id pub-id-type="pmid">23608960</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>G.</given-names></name><name><surname>Goettsch</surname><given-names>C.</given-names></name><name><surname>Morawietz</surname><given-names>H.</given-names></name></person-group><article-title>Oxidative stress and endothelial dysfunction</article-title><source><italic toggle="yes">Hämostaseologie</italic></source><year>2007</year><volume>27</volume><issue>1</issue><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1055/s-0037-1616894</pub-id><pub-id pub-id-type="pmid">17279271</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><etal></etal></person-group><article-title>Scutellarin protects against vascular endothelial dysfunction and prevents atherosclerosis via antioxidation</article-title><source><italic toggle="yes">Phytomedicine</italic></source><year>2018</year><volume>42</volume><fpage>66</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2018.03.021</pub-id><pub-id pub-id-type="other">2-s2.0-85044159176</pub-id><pub-id pub-id-type="pmid">29655699</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H. Y.</given-names></name><name><surname>Kim</surname><given-names>S. W.</given-names></name><name><surname>Lee</surname><given-names>G. H.</given-names></name><etal></etal></person-group><article-title>Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2016</year><volume>16</volume><issue>1</issue><fpage>p. 316</fpage><pub-id pub-id-type="doi">10.1186/s12906-016-1307-6</pub-id><pub-id pub-id-type="other">2-s2.0-84983655891</pub-id><pub-id pub-id-type="pmid">27561811</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>T.</given-names></name><name><surname>Shieh</surname><given-names>Y.</given-names></name></person-group><article-title>Emulsification and antioxidation of biosurfactant extracts from Chinese medicinal herbs fermentation in vitro</article-title><source><italic toggle="yes">Journal of Bioscience and Bioengineering</italic></source><year>2015</year><volume>120</volume><issue>4</issue><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1016/j.jbiosc.2015.02.010</pub-id><pub-id pub-id-type="other">2-s2.0-84940897688</pub-id><pub-id pub-id-type="pmid">25812919</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Murakami</surname><given-names>K.</given-names></name><name><surname>Yoshino</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation</article-title><source><italic toggle="yes">Food and Chemical Toxicology: An International Journal Published For The British Industrial Biological Research Association</italic></source><year>2005</year><volume>43</volume><issue>3</issue><fpage>461</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2004.11.019</pub-id><pub-id pub-id-type="other">2-s2.0-12844273587</pub-id><pub-id pub-id-type="pmid">15680683</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagababu</surname><given-names>E.</given-names></name><name><surname>Rifkind</surname><given-names>J. M.</given-names></name><name><surname>Boindala</surname><given-names>S.</given-names></name><name><surname>Nakka</surname><given-names>L.</given-names></name></person-group><article-title>Assessment of antioxidant activity of eugenol in vitro and in vivo</article-title><source><italic toggle="yes">Methods in Molecular Biology</italic></source><year>2010</year><volume>610</volume><fpage>165</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1007/978-1-60327-029-8_10</pub-id><pub-id pub-id-type="pmid">20013178</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magalhães</surname><given-names>C. B.</given-names></name><name><surname>Riva</surname><given-names>D. R.</given-names></name><name><surname>DePaula</surname><given-names>L. J.</given-names></name><etal></etal></person-group><article-title>In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury</article-title><source><italic toggle="yes">Journal of Applied Physiology</italic></source><year>2010</year><volume>108</volume><issue>4</issue><fpage>845</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00560.2009</pub-id><pub-id pub-id-type="other">2-s2.0-77950554467</pub-id><pub-id pub-id-type="pmid">20075264</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezerra</surname><given-names>D. P.</given-names></name><name><surname>Militao</surname><given-names>G. C. G.</given-names></name><name><surname>de Morais</surname><given-names>M. C.</given-names></name><name><surname>de Sousa</surname><given-names>D. P.</given-names></name></person-group><article-title>The dual antioxidant/prooxidant effect of eugenol and its action in cancer development and treatment</article-title><source><italic toggle="yes">Nutrients</italic></source><year>2017</year><volume>9</volume><issue>12</issue><fpage>p. 1367</fpage><pub-id pub-id-type="doi">10.3390/nu9121367</pub-id><pub-id pub-id-type="other">2-s2.0-85038595866</pub-id><pub-id pub-id-type="pmid">29258206</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>B. S.</given-names></name><name><surname>Song</surname><given-names>Y. S.</given-names></name><name><surname>Yee</surname><given-names>S. B.</given-names></name><etal></etal></person-group><article-title>Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis</article-title><source><italic toggle="yes">Apoptosis</italic></source><year>2005</year><volume>10</volume><issue>1</issue><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1007/s10495-005-6074-7</pub-id><pub-id pub-id-type="other">2-s2.0-17644407682</pub-id><pub-id pub-id-type="pmid">15711935</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerosa</surname><given-names>R.</given-names></name><name><surname>Borin</surname><given-names>M.</given-names></name><name><surname>Menegazzi</surname><given-names>G.</given-names></name><name><surname>Puttini</surname><given-names>M.</given-names></name><name><surname>Cavalleri</surname><given-names>G.</given-names></name></person-group><article-title>In vitro evaluation of the cytotoxicity of pure eugenol</article-title><source><italic toggle="yes">Journal of Endodontics</italic></source><year>1996</year><volume>22</volume><issue>10</issue><fpage>532</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/S0099-2399(96)80012-4</pub-id><pub-id pub-id-type="other">2-s2.0-0030252658</pub-id><pub-id pub-id-type="pmid">9198440</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soundran</surname><given-names>V.</given-names></name><name><surname>Namagiri</surname><given-names>T.</given-names></name><name><surname>Manonayaki</surname><given-names>S.</given-names></name><name><surname>Vanithakumari</surname><given-names>G.</given-names></name></person-group><article-title>Hepatotoxicity of eugenol</article-title><source><italic toggle="yes">Ancient Science of Life</italic></source><year>1994</year><volume>13</volume><issue>3-4</issue><fpage>213</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">22556649</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nascimento-Silva</surname><given-names>V.</given-names></name><name><surname>Arruda</surname><given-names>M. A.</given-names></name><name><surname>Barja-Fidalgo</surname><given-names>C.</given-names></name><name><surname>Fierro</surname><given-names>I. M.</given-names></name></person-group><article-title>Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism</article-title><source><italic toggle="yes">Thrombosis and Haemostasis</italic></source><year>2007</year><volume>97</volume><issue>1</issue><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">17200775</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>W.</given-names></name><name><surname>Muller</surname><given-names>T.</given-names></name><name><surname>Buttner</surname><given-names>T.</given-names></name><name><surname>Gerlach</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidative properties of aspirin: dose dependence and clinical implications</article-title><source><italic toggle="yes">European Journal of Neurology</italic></source><year>1996</year><volume>3</volume><issue>3</issue><fpage>275</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1111/j.1468-1331.1996.tb00436.x</pub-id><pub-id pub-id-type="other">2-s2.0-0030004705</pub-id><pub-id pub-id-type="pmid">21284783</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demirci</surname><given-names>B.</given-names></name><name><surname>Demir</surname><given-names>O.</given-names></name><name><surname>Dost</surname><given-names>T.</given-names></name><name><surname>Birincioglu</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidative effect of aspirin on vascular function of aged ovariectomized rats</article-title><source><italic toggle="yes">Age</italic></source><year>2014</year><volume>36</volume><issue>1</issue><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1007/s11357-013-9569-0</pub-id><pub-id pub-id-type="other">2-s2.0-84899077459</pub-id><pub-id pub-id-type="pmid">23872923</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J. Y.</given-names></name><name><surname>Yu</surname><given-names>Y. G.</given-names></name><name><surname>Wang</surname><given-names>Q. W.</given-names></name><etal></etal></person-group><article-title>Synthesis of aspirin eugenol ester and its biological activity</article-title><source><italic toggle="yes">Medicinal Chemistry Research</italic></source><year>2012</year><volume>21</volume><issue>7</issue><fpage>995</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1007/s00044-011-9609-1</pub-id><pub-id pub-id-type="other">2-s2.0-84861908418</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J. Y.</given-names></name><name><surname>Yu</surname><given-names>Y. G.</given-names></name><name><surname>Yang</surname><given-names>Y. J.</given-names></name><etal></etal></person-group><article-title>Antioxidant activity of aspirin eugenol ester for aging model of mice by D-galactose</article-title><source><italic toggle="yes">Journal of Animal and Veterinary Advances</italic></source><year>2012</year><volume>11</volume><fpage>4401</fpage><lpage>4405</lpage></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M. Z.</given-names></name><name><surname>Yang</surname><given-names>Y. J.</given-names></name><name><surname>Liu</surname><given-names>X. W.</given-names></name><name><surname>Qin</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>J. Y.</given-names></name></person-group><article-title>Aspirin eugenol ester attenuates oxidative injury of vascular endothelial cells by regulating NOS and Nrf2 signalling pathways</article-title><source><italic toggle="yes">British Journal of Pharmacology</italic></source><year>2019</year><volume>176</volume><issue>7</issue><fpage>906</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1111/bph.14592</pub-id><pub-id pub-id-type="other">2-s2.0-85062799255</pub-id><pub-id pub-id-type="pmid">30706438</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzuto</surname><given-names>R.</given-names></name><name><surname>Pinton</surname><given-names>P.</given-names></name><name><surname>De Stefani</surname><given-names>D.</given-names></name><etal></etal></person-group><article-title>Mitochondria, calcium signaling and cell death by apoptosis and autophagy</article-title><source><italic toggle="yes">Biochimica et Biophysica Acta (BBA) - Bioenergetics</italic></source><year>2010</year><volume>1797</volume><fpage>p. 4</fpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2010.04.031</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boya</surname><given-names>P.</given-names></name><name><surname>Gonzalez-Polo</surname><given-names>R. A.</given-names></name><name><surname>Poncet</surname><given-names>D.</given-names></name><etal></etal></person-group><article-title>Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine</article-title><source><italic toggle="yes">Oncogene</italic></source><year>2003</year><volume>22</volume><issue>25</issue><fpage>3927</fpage><lpage>3936</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1206622</pub-id><pub-id pub-id-type="other">2-s2.0-0038677510</pub-id><pub-id pub-id-type="pmid">12813466</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appelqvist</surname><given-names>H.</given-names></name><name><surname>Johansson</surname><given-names>A. C.</given-names></name><name><surname>Linderoth</surname><given-names>E.</given-names></name><etal></etal></person-group><article-title>Lysosome-mediated apoptosis is associated with cathepsin D-specific processing of Bid at Phe24,Trp48, and Phe183</article-title><source><italic toggle="yes">Annals of Clinical and Laboratory Science</italic></source><year>2012</year><volume>42</volume><issue>3</issue><fpage>231</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">22964611</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunk</surname><given-names>U. T.</given-names></name><name><surname>Neuzil</surname><given-names>J.</given-names></name><name><surname>Eaton</surname><given-names>J. W.</given-names></name></person-group><article-title>Lysosomal involvement in apoptosis</article-title><source><italic toggle="yes">Redox Report</italic></source><year>2001</year><volume>6</volume><issue>2</issue><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1179/135100001101536094</pub-id><pub-id pub-id-type="other">2-s2.0-0034983544</pub-id><pub-id pub-id-type="pmid">11450988</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temkin</surname><given-names>V.</given-names></name><name><surname>Liu</surname><given-names>H. T.</given-names></name><name><surname>Ma</surname><given-names>Y. Y.</given-names></name><name><surname>Pope</surname><given-names>R. M.</given-names></name></person-group><article-title>Lysosome-mitochondrion cross-talk is indispensable for TNF alpha-induced apoptosis</article-title><source><italic toggle="yes">Arthritis and Rheumatism</italic></source><year>2004</year><volume>50, article S114</volume></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorin</surname><given-names>E.</given-names></name><name><surname>Shreeve</surname><given-names>S. M.</given-names></name></person-group><article-title>Heterogeneity of vascular endothelial cells in normal and disease states</article-title><source><italic toggle="yes">Pharmacology & Therapeutics</italic></source><year>1998</year><volume>78</volume><issue>3</issue><fpage>155</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/S0163-7258(98)00005-9</pub-id><pub-id pub-id-type="other">2-s2.0-0031750576</pub-id><pub-id pub-id-type="pmid">9690816</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzugkoeva</surname><given-names>F. S.</given-names></name><name><surname>Mozhaeva</surname><given-names>I. V.</given-names></name><name><surname>Dzugkoev</surname><given-names>S. G.</given-names></name><name><surname>Margieva</surname><given-names>O. I.</given-names></name><name><surname>Tedtoeva</surname><given-names>A. I.</given-names></name><name><surname>Otiev</surname><given-names>M. A.</given-names></name></person-group><article-title>Oxidative stress and biochemical markers of endothelial dysfunction and organ damage under conditions of experimental nonferrous metal intoxication</article-title><source><italic toggle="yes">Bulletin of Experimental Biology and Medicine</italic></source><year>2016</year><volume>162</volume><issue>2</issue><fpage>199</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1007/s10517-016-3575-z</pub-id><pub-id pub-id-type="other">2-s2.0-85011961004</pub-id><pub-id pub-id-type="pmid">27909964</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czerska</surname><given-names>M.</given-names></name><name><surname>Mikolajewska</surname><given-names>K.</given-names></name><name><surname>Zielinski</surname><given-names>M.</given-names></name><name><surname>Gromadzinska</surname><given-names>J.</given-names></name><name><surname>Wasowicz</surname><given-names>W.</given-names></name></person-group><article-title>Today’s oxidative stress markers</article-title><source><italic toggle="yes">Medycyna Pracy</italic></source><year>2015</year><volume>66</volume><issue>3</issue><fpage>393</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.13075/mp.5893.00137</pub-id><pub-id pub-id-type="other">2-s2.0-84942777559</pub-id><pub-id pub-id-type="pmid">26325052</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B.</given-names></name><name><surname>Whiteman</surname><given-names>M.</given-names></name></person-group><article-title>Measuring reactive species and oxidative damage <italic>in vivo</italic> and in cell culture: how should you do it and what do the results mean?</article-title><source><italic toggle="yes">British Journal of Pharmacology</italic></source><year>2004</year><volume>142</volume><issue>2</issue><fpage>231</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0705776</pub-id><pub-id pub-id-type="other">2-s2.0-2942572700</pub-id><pub-id pub-id-type="pmid">15155533</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. K.</given-names></name><name><surname>Hong</surname><given-names>Y. J.</given-names></name><name><surname>Wei</surname><given-names>M.</given-names></name><etal></etal></person-group><article-title>Curculigoside attenuates human umbilical vein endothelial cell injury induced by H<sub>2</sub>O<sub>2</sub></article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2010</year><volume>132</volume><issue>1</issue><fpage>233</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.08.008</pub-id><pub-id pub-id-type="other">2-s2.0-77957772339</pub-id><pub-id pub-id-type="pmid">20713149</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>D. P.</given-names></name></person-group><article-title>[11] Redox potential of GSH/GSSG couple: assay and biological significance</article-title><source><italic toggle="yes">Methods in Enzymology</italic></source><year>2002</year><volume>348</volume><fpage>93</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(02)48630-2</pub-id><pub-id pub-id-type="other">2-s2.0-0036372619</pub-id><pub-id pub-id-type="pmid">11885298</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buttke</surname><given-names>T. M.</given-names></name><name><surname>Sandstrom</surname><given-names>P. A.</given-names></name></person-group><article-title>Oxidative stress as a mediator of apoptosis</article-title><source><italic toggle="yes">Immunology Today</italic></source><year>1994</year><volume>15</volume><issue>1</issue><fpage>7</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/0167-5699(94)90018-3</pub-id><pub-id pub-id-type="other">2-s2.0-0028176651</pub-id><pub-id pub-id-type="pmid">8136014</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mates</surname><given-names>J. M.</given-names></name><name><surname>Segura</surname><given-names>J. A.</given-names></name><name><surname>Alonso</surname><given-names>F. J.</given-names></name><name><surname>Marquez</surname><given-names>J.</given-names></name></person-group><article-title>Oxidative stress in apoptosis and cancer: an update</article-title><source><italic toggle="yes">Archives of Toxicology</italic></source><year>2012</year><volume>86</volume><issue>11</issue><fpage>1649</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.1007/s00204-012-0906-3</pub-id><pub-id pub-id-type="other">2-s2.0-84871232740</pub-id><pub-id pub-id-type="pmid">22811024</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>T.</given-names></name><name><surname>Terman</surname><given-names>A.</given-names></name><name><surname>Gustafsson</surname><given-names>B.</given-names></name><name><surname>Brunk</surname><given-names>U. T.</given-names></name></person-group><article-title>Lysosomes and oxidative stress in aging and apoptosis</article-title><source><italic toggle="yes">Biochimica et Biophysica Acta (BBA) - General Subjects</italic></source><year>2008</year><volume>1780</volume><issue>11</issue><fpage>1291</fpage><lpage>1303</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2008.01.009</pub-id><pub-id pub-id-type="other">2-s2.0-49349090381</pub-id><pub-id pub-id-type="pmid">18255041</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>K.</given-names></name><name><surname>Das</surname><given-names>J.</given-names></name><name><surname>Pal</surname><given-names>P. B.</given-names></name><name><surname>Sil</surname><given-names>P. C.</given-names></name></person-group><article-title>Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis</article-title><source><italic toggle="yes">Archives of Toxicology</italic></source><year>2013</year><volume>87</volume><issue>7</issue><fpage>1157</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1007/s00204-013-1034-4</pub-id><pub-id pub-id-type="other">2-s2.0-84879165160</pub-id><pub-id pub-id-type="pmid">23543009</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cocchiaro</surname><given-names>P.</given-names></name><name><surname>Fox</surname><given-names>C.</given-names></name><name><surname>Tregidgo</surname><given-names>N. W.</given-names></name><etal></etal></person-group><article-title>Lysosomal protease cathepsin D; a new driver of apoptosis during acute kidney injury</article-title><source><italic toggle="yes">Scientific Reports</italic></source><year>2016</year><volume>6</volume><issue>1, article 27112</issue><pub-id pub-id-type="doi">10.1038/srep27112</pub-id><pub-id pub-id-type="other">2-s2.0-84976344598</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blomgran</surname><given-names>R.</given-names></name><name><surname>Stendahl</surname><given-names>O.</given-names></name></person-group><article-title>Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization</article-title><source><italic toggle="yes">European Journal of Clinical Investigation</italic></source><year>2007</year><volume>37</volume><fpage>p. 28</fpage></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>A. C.</given-names></name><name><surname>Appelqvist</surname><given-names>H.</given-names></name><name><surname>Nilsson</surname><given-names>C.</given-names></name><name><surname>Kågedal</surname><given-names>K.</given-names></name><name><surname>Roberg</surname><given-names>K.</given-names></name><name><surname>Öllinger</surname><given-names>K.</given-names></name></person-group><article-title>Regulation of apoptosis-associated lysosomal membrane permeabilization</article-title><source><italic toggle="yes">Apoptosis</italic></source><year>2010</year><volume>15</volume><issue>5</issue><fpage>527</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1007/s10495-009-0452-5</pub-id><pub-id pub-id-type="other">2-s2.0-77951666702</pub-id><pub-id pub-id-type="pmid">20077016</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terman</surname><given-names>A.</given-names></name><name><surname>Gustafsson</surname><given-names>B.</given-names></name><name><surname>Brunk</surname><given-names>U. T.</given-names></name></person-group><article-title>The lysosomal-mitochondrial axis theory of postmitotic aging and cell death</article-title><source><italic toggle="yes">Chemico-Biological Interactions</italic></source><year>2006</year><volume>163</volume><issue>1-2</issue><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2006.04.013</pub-id><pub-id pub-id-type="other">2-s2.0-33749656530</pub-id><pub-id pub-id-type="pmid">16737690</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>AEE reduced the apoptosis of HUVECs induced by H<sub>2</sub>O<sub>2</sub>. (a) The double stained with Annexin V and PI results among different treatment groups. (b) The apoptosis rate among different treatment groups. Values were expressed as mean ± SD, <italic>n</italic> = 6; <sup>∗</sup><italic>p</italic> < 0.05, compared with the normal group; <sup>#</sup><italic>p</italic> < 0.05, compared with the group treated with H<sub>2</sub>O<sub>2</sub> alone (one-way ANOVA followed with Duncan's multiple comparisons).</p></caption><graphic xlink:href="OMCL2019-8098135.001"></graphic></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>AEE enhanced the antioxidant capacity of HUVECs. (a) AEE decreased lipid peroxidation in the HUVECs. (b) AEE enhanced the SOD activity. (c) AEE raised the GSH-Px activity. (d) AEE increased the ratio of GSH to GSSG. Values were expressed as mean ± SD, <italic>n</italic> = 6; <sup>∗</sup><italic>p</italic> < 0.05, compared with the normal group; <sup>#</sup><italic>p</italic> < 0.05, compared with the group treated with H<sub>2</sub>O<sub>2</sub> alone (one-way ANOVA followed with Duncan's multiple comparisons).</p></caption><graphic xlink:href="OMCL2019-8098135.002"></graphic></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>AEE ameliorated lysosomal disorder induced by H<sub>2</sub>O<sub>2</sub>. (a, b) AEE reduced the expression of mature CTSD induced by H<sub>2</sub>O<sub>2</sub>. (c) AEE reduced the increase in CTSD activity induced by H<sub>2</sub>O<sub>2</sub>. The high-density fluorescence of LysoTracker Red was indicated by green arrows. (d, e) AEE enhanced the stability of the lysosomal membrane disrupted by H<sub>2</sub>O<sub>2</sub> ((d) 10 × 40 power). “+” including the treatment in the HUVECs; “-”excluding the treatment on the HUVECs. Values are expressed as mean ± SD, <italic>n</italic> = 6; <sup>∗</sup><italic>p</italic> < 0.05, compared with the normal group; <sup>#</sup><italic>p</italic> < 0.05, compared with the group of H<sub>2</sub>O<sub>2</sub> alone (one-way ANOVA followed with Duncan's multiple comparisons).</p></caption><graphic xlink:href="OMCL2019-8098135.003"></graphic></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>AEE alleviated the mitochondrial dysfunction induced by H<sub>2</sub>O<sub>2</sub>. (a, b) AEE reduced the collapse of the mitochondrial membrane potential induced by H<sub>2</sub>O<sub>2</sub> ((a) 10 × 40 power). (c, d) AEE reduced the generation of cellular and mitochondrial ROS induced by H<sub>2</sub>O<sub>2</sub> (upper part of (c): 10 × 10 power; lower part of (c): 10 × 40 power); “+” with the treatment in the HUVECs, “-” excluding the treatment on the HUVECs. (e, f) AEE prevented the release of Cyt c from mitochondria ((e) 10 × 40 power). Values are expressed as mean ± SD, <italic>n</italic> = 6; <sup>∗</sup><italic>p</italic> < 0.05, compared with the normal group; <sup>#</sup><italic>p</italic> < 0.05, compared with the group of H<sub>2</sub>O<sub>2</sub> alone (one-way ANOVA followed with Duncan's multiple comparisons).</p></caption><graphic xlink:href="OMCL2019-8098135.004"></graphic></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>AEE treatment reduced the effect of H<sub>2</sub>O<sub>2</sub> on antiapoptosis or proapoptosis proteins. (a, b) AEE reduced H<sub>2</sub>O<sub>2</sub>-induced expression of mature Cas3 and Bid and reversed the H<sub>2</sub>O<sub>2</sub>-inhibited expression of Bcl2 and Bcl-XL. (c, d) AEE reduced H<sub>2</sub>O<sub>2</sub>-induced expression of Bax ((c) 10 × 40 power). “+” with the treatment in the HUVECs; “-” without the treatment in the HUVECs. Values are expressed as mean ± SD, <italic>n</italic> = 6; <sup>∗</sup><italic>p</italic> < 0.05, compared with the normal group; <sup>#</sup><italic>p</italic> < 0.05, compared with the group of H<sub>2</sub>O<sub>2</sub> alone.</p></caption><graphic xlink:href="OMCL2019-8098135.005"></graphic></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Genetic inhibition of Bcl2 reduced the effect of AEE on H<sub>2</sub>O<sub>2</sub>-induced mitochondrial and lysosomal dysfunction. (a, b) The changes in the mitochondrial membrane potential between different treatment groups ((a) 10 × 40 power). (c, d) The changes in ROS production between different treatment groups ((c) 10 × 40 power). (e, f) The changes in CTSD and Cas3 activity among different treatment groups. “+” with the treatment in the HUVECs; “-” without the treatment in the HUVECs. Values are expressed as mean ± SD, <italic>n</italic> = 6; <sup>∗</sup><italic>p</italic> < 0.05, compared with the group of overexpression alone; <sup>#</sup><italic>p</italic> < 0.05, compared with the group of H<sub>2</sub>O<sub>2</sub> alone (one-way ANOVA followed with Duncan's multiple comparisons).</p></caption><graphic xlink:href="OMCL2019-8098135.006"></graphic></fig></floats-group></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000761 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000761 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:6754946
|texte= Aspirin Eugenol Ester Reduces H2O2-Induced Oxidative Stress of HUVECs via Mitochondria-Lysosome Axis
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:31583045" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |